Recurrence-free survival varied among subtypes, with POLE-mutated cases having the most favorable outcome and p53-abnormal cases the poorest, although these differences did not reach statistical significance, likely attributable to the limited sample size and short follow-up period.
← all excerpts
Evaluation of the TCGA-Surrogate (ProMisE) Molecular Classification and Clinical Features of Endometrial Carcinoma: A Study of 97 Cases from China.
1
—
—